IL143181A0 - Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system - Google Patents

Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system

Info

Publication number: IL143181A0
Authority: IL; Israel
Prior art keywords: nervous system; central nervous; treating diseases; azabicycloalkane derivatives; substituted
Prior art date: 1998-11-24

Application number

IL14318199A

Original Assignee

Basf Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-24

Filing date

1999-11-12

Publication date

2002-04-21

1999-11-12 Application filed by Basf Ag filed Critical Basf Ag

2002-04-21 Publication of IL143181A0 publication Critical patent/IL143181A0/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Psychiatry (AREA)
Addiction (AREA)
Epidemiology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Indole Compounds (AREA)

IL14318199A 1998-11-24 1999-11-12 Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system IL143181A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19854147A DE19854147A1 (en)	1998-11-24	1998-11-24	Control of cocaine addiction comprises administration of N-substituted azabicycloalkane derivative
PCT/EP1999/008734 WO2000030639A1 (en)	1998-11-24	1999-11-12	Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system

Publications (1)

Publication Number	Publication Date
IL143181A0 true IL143181A0 (en)	2002-04-21

Family

ID=7888824

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL14318199A IL143181A0 (en)	1998-11-24	1999-11-12	Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system

Country Status (21)

Country	Link
EP (1)	EP1133293A1 (en)
JP (1)	JP2002530333A (en)
KR (1)	KR20010080535A (en)
CN (1)	CN1328455A (en)
AR (1)	AR021502A1 (en)
AU (1)	AU1775300A (en)
BG (1)	BG105549A (en)
BR (1)	BR9915589A (en)
CA (1)	CA2352526A1 (en)
CZ (1)	CZ20011796A3 (en)
DE (1)	DE19854147A1 (en)
HK (1)	HK1040933A1 (en)
HR (1)	HRP20010472A2 (en)
HU (1)	HUP0104416A3 (en)
IL (1)	IL143181A0 (en)
NO (1)	NO20012538L (en)
PL (1)	PL348758A1 (en)
SK (1)	SK7112001A3 (en)
TR (1)	TR200101476T2 (en)
WO (1)	WO2000030639A1 (en)
ZA (1)	ZA200103976B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BRPI0519013A2 (en)	2004-12-13	2009-11-03	Lilly Co Eli	single compound or stereoisomers, mixtures of pharmaceutically acceptable stereoisomers, salts, tautomers or prodrugs thereof, pharmaceutical composition, and use of a compound
GB0812310D0 (en)	2008-07-03	2008-08-13	Syngenta Ltd	Novel herbicides
MX379289B (en) *	2013-01-15	2025-03-10	Novartis Ag	USE OF ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2717288A (en) *	1987-11-12	1989-06-01	American Home Products Corporation	Polycyclicamines with psychotropic activity
DE4427648A1 (en) *	1994-08-04	1996-02-08	Basf Ag	N-Stubstituted 3-azabicyclo [3,2,0,] heptane derivatives, their preparation and use
DE4341403A1 (en) *	1993-12-04	1995-06-08	Basf Ag	N-substituted 3-azabicycloalkane derivatives, their preparation and use
DE4427647A1 (en) *	1994-08-04	1996-02-08	Basf Ag	N-substituted azabicycloheptane derivatives, their preparation and use

1998
- 1998-11-24 DE DE19854147A patent/DE19854147A1/en not_active Withdrawn
1999
- 1999-11-12 CA CA002352526A patent/CA2352526A1/en not_active Abandoned
- 1999-11-12 IL IL14318199A patent/IL143181A0/en unknown
- 1999-11-12 HU HU0104416A patent/HUP0104416A3/en unknown
- 1999-11-12 AU AU17753/00A patent/AU1775300A/en not_active Abandoned
- 1999-11-12 BR BR9915589-3A patent/BR9915589A/en not_active IP Right Cessation
- 1999-11-12 EP EP99960974A patent/EP1133293A1/en not_active Withdrawn
- 1999-11-12 WO PCT/EP1999/008734 patent/WO2000030639A1/en not_active Application Discontinuation
- 1999-11-12 KR KR1020017006445A patent/KR20010080535A/en not_active Application Discontinuation
- 1999-11-12 SK SK711-2001A patent/SK7112001A3/en unknown
- 1999-11-12 TR TR2001/01476T patent/TR200101476T2/en unknown
- 1999-11-12 JP JP2000583522A patent/JP2002530333A/en active Pending
- 1999-11-12 CZ CZ20011796A patent/CZ20011796A3/en unknown
- 1999-11-12 PL PL99348758A patent/PL348758A1/en not_active Application Discontinuation
- 1999-11-12 CN CN99813559A patent/CN1328455A/en active Pending
- 1999-11-24 AR ARP990105979A patent/AR021502A1/en unknown
2001
- 2001-05-16 ZA ZA200103976A patent/ZA200103976B/en unknown
- 2001-05-23 NO NO20012538A patent/NO20012538L/en not_active Application Discontinuation
- 2001-05-30 BG BG105549A patent/BG105549A/en unknown
- 2001-06-21 HR HR20010472A patent/HRP20010472A2/en not_active Application Discontinuation
2002
- 2002-04-12 HK HK02102768.4A patent/HK1040933A1/en unknown

Also Published As

Publication number	Publication date
DE19854147A1 (en)	2000-05-25
HUP0104416A3 (en)	2002-11-28
BG105549A (en)	2001-12-29
CA2352526A1 (en)	2000-06-02
CZ20011796A3 (en)	2002-05-15
WO2000030639A1 (en)	2000-06-02
HRP20010472A2 (en)	2003-04-30
EP1133293A1 (en)	2001-09-19
AR021502A1 (en)	2002-07-24
NO20012538D0 (en)	2001-05-23
BR9915589A (en)	2001-08-07
CN1328455A (en)	2001-12-26
ZA200103976B (en)	2002-05-16
JP2002530333A (en)	2002-09-17
NO20012538L (en)	2001-07-04
TR200101476T2 (en)	2001-10-22
PL348758A1 (en)	2002-06-03
SK7112001A3 (en)	2001-12-03
HUP0104416A2 (en)	2002-04-29
HK1040933A1 (en)	2002-06-28
AU1775300A (en)	2000-06-13
KR20010080535A (en)	2001-08-22

Similar Documents

Publication	Publication Date	Title
GB2305605B (en)	2000-01-12	Pipecolic acid derivatives for the treatment of neurological disorders
HUP0103856A3 (en)	2003-11-28	Pharmaceutical composition for the treatment of acute disorders
PL344304A1 (en)	2001-10-22	Combination therapy for treatment of bipolar disorders
IL138129A (en)	2005-06-19	Composition for therapy of estrogen-associated disorders
IL155589A0 (en)	2003-11-23	Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
PL350679A1 (en)	2003-01-27	Derivatives of 1-arenosulphonyl-2-arylpyrolydine and piperidine for treating central nervous system disorders
IL141263A0 (en)	2002-03-10	Methods for treatment of neurological disorders
SI0908458T1 (en)	2006-06-30	Substituted pyridylmethylpiperazine and piperidine derivatives, their preparation and their use for treating central nervous system (CNS) disorders
EP1207874A4 (en)	2004-02-11	Methods of treating proliferative disorders
AU7788500A (en)	2001-05-08	Use of substance p antagonists for influencing the circadian timing system
EE200000391A (en)	2002-02-15	Triazine compounds for the treatment of central nervous system disorders
ATE256126T1 (en)	2003-12-15	5-HETEROATOM-ALKYL SUBSTITUTED 3-OXO-PYRIDO(1,2-A)BENZIMIDAZOLE-4-CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
HUP0104701A3 (en)	2003-01-28	3-tetrahydropyridin-4-yl indoles for treatment of psychotic disorders and medicaments containing the compounds
HK1038510B (en)	2005-05-20	Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases
IL143181A0 (en)	2002-04-21	Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system
HUP9902167A3 (en)	2000-07-28	Use of phenylnaphthalene derivatives to make medicaments for treating diseases of the central nervous system
HUP0100365A3 (en)	2002-06-28	Combination therapy for the treatment of aids
IL136949A0 (en)	2001-06-14	1,4-diazacycloheptane derivatives for the treatment of neurological disorders
PT1011678E (en)	2008-02-07	Use of mecamylamine for the treatment of nicotine-responsive neuropsychiatric disorders
GB0010496D0 (en)	2000-06-14	Treatment of conditions of the central nervous system
GB9901808D0 (en)	1999-03-17	Drugs for treatment of psychiatric and brain disorders
GB9821610D0 (en)	1998-11-25	Treatment of neuropsychiatric disorders
GB9923551D0 (en)	1999-12-08	Treatment of neuropsychiatric disorders
SI1133290T1 (en)	2003-06-30	Use of inhibitors of acetylcholinesterase for the treatment of deliriums
UA25221A (en)	1998-12-25	METHOD OF TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM

Legal Events

Date	Code	Title	Description
2003-05-29	HP	Change in proprietorship